
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Xianding Deng, Miguel Garcia-Knight, Mir M. Khalid, et al.
Cell (2021) Vol. 184, Iss. 13, pp. 3426-3437.e8
Open Access | Times Cited: 513
Xianding Deng, Miguel Garcia-Knight, Mir M. Khalid, et al.
Cell (2021) Vol. 184, Iss. 13, pp. 3426-3437.e8
Open Access | Times Cited: 513
Showing 1-25 of 513 citing articles:
Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Chang Liu, Helen M. Ginn, Wanwisa Dejnirattisai, et al.
Cell (2021) Vol. 184, Iss. 16, pp. 4220-4236.e13
Open Access | Times Cited: 708
Chang Liu, Helen M. Ginn, Wanwisa Dejnirattisai, et al.
Cell (2021) Vol. 184, Iss. 16, pp. 4220-4236.e13
Open Access | Times Cited: 708
Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
Jiahui Chen, Rui Wang, Nancy Benovich Gilby, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 2, pp. 412-422
Open Access | Times Cited: 639
Jiahui Chen, Rui Wang, Nancy Benovich Gilby, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 2, pp. 412-422
Open Access | Times Cited: 639
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
Sarah Cherian, Varsha Potdar, Santosh Jadhav, et al.
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1542-1542
Open Access | Times Cited: 628
Sarah Cherian, Varsha Potdar, Santosh Jadhav, et al.
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1542-1542
Open Access | Times Cited: 628
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
Alison Tarke, John Sidney, Nils Methot, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100355-100355
Open Access | Times Cited: 618
Alison Tarke, John Sidney, Nils Methot, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100355-100355
Open Access | Times Cited: 618
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1124-1136.e11
Open Access | Times Cited: 518
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1124-1136.e11
Open Access | Times Cited: 518
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Science (2021) Vol. 373, Iss. 6555, pp. 648-654
Open Access | Times Cited: 439
Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Science (2021) Vol. 373, Iss. 6555, pp. 648-654
Open Access | Times Cited: 439
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 402
Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 402
Tackling COVID-19 with neutralizing monoclonal antibodies
Davide Corti, Lisa A. Purcell, Gyorgy Snell, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3086-3108
Open Access | Times Cited: 369
Davide Corti, Lisa A. Purcell, Gyorgy Snell, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3086-3108
Open Access | Times Cited: 369
The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic
Sarah P. Otto, Troy Day, Julien Arino, et al.
Current Biology (2021) Vol. 31, Iss. 14, pp. R918-R929
Open Access | Times Cited: 323
Sarah P. Otto, Troy Day, Julien Arino, et al.
Current Biology (2021) Vol. 31, Iss. 14, pp. R918-R929
Open Access | Times Cited: 323
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
Jinhui Dong, Seth J. Zost, Allison J. Greaney, et al.
Nature Microbiology (2021) Vol. 6, Iss. 10, pp. 1233-1244
Open Access | Times Cited: 305
Jinhui Dong, Seth J. Zost, Allison J. Greaney, et al.
Nature Microbiology (2021) Vol. 6, Iss. 10, pp. 1233-1244
Open Access | Times Cited: 305
Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles
Abdullah M. Syed, Taha Y. Taha, Takako Tabata, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1626-1632
Open Access | Times Cited: 290
Abdullah M. Syed, Taha Y. Taha, Takako Tabata, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1626-1632
Open Access | Times Cited: 290
SARS-CoV-2 Variants of Concern
Jun Yong Choi, Davey M. Smith
Yonsei Medical Journal (2021) Vol. 62, Iss. 11, pp. 961-961
Open Access | Times Cited: 274
Jun Yong Choi, Davey M. Smith
Yonsei Medical Journal (2021) Vol. 62, Iss. 11, pp. 961-961
Open Access | Times Cited: 274
Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness
Fritz Obermeyer, Martin Jankowiak, Nikolaos Barkas, et al.
Science (2022) Vol. 376, Iss. 6599, pp. 1327-1332
Open Access | Times Cited: 274
Fritz Obermeyer, Martin Jankowiak, Nikolaos Barkas, et al.
Science (2022) Vol. 376, Iss. 6599, pp. 1327-1332
Open Access | Times Cited: 274
Broad sarbecovirus neutralization by a human monoclonal antibody
M. Alejandra Tortorici, Nadine Czudnochowski, Tyler N. Starr, et al.
Nature (2021) Vol. 597, Iss. 7874, pp. 103-108
Open Access | Times Cited: 272
M. Alejandra Tortorici, Nadine Czudnochowski, Tyler N. Starr, et al.
Nature (2021) Vol. 597, Iss. 7874, pp. 103-108
Open Access | Times Cited: 272
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Rita E. Chen, Emma S. Winkler, James Brett Case, et al.
Nature (2021) Vol. 596, Iss. 7870, pp. 103-108
Open Access | Times Cited: 251
Rita E. Chen, Emma S. Winkler, James Brett Case, et al.
Nature (2021) Vol. 596, Iss. 7870, pp. 103-108
Open Access | Times Cited: 251
Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021
Alyson M. Cavanaugh, Kevin B. Spicer, Douglas Thoroughman, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 32, pp. 1081-1083
Open Access | Times Cited: 243
Alyson M. Cavanaugh, Kevin B. Spicer, Douglas Thoroughman, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 32, pp. 1081-1083
Open Access | Times Cited: 243
Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
Emerging SARS-CoV-2 variants of concern and potential intervention approaches
Jasmin Khateeb, Yuchong Li, Haibo Zhang
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 228
Jasmin Khateeb, Yuchong Li, Haibo Zhang
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 228
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
Yaping Wang, Ruchong Chen, Fengyu Hu, et al.
EClinicalMedicine (2021) Vol. 40, pp. 101129-101129
Open Access | Times Cited: 216
Yaping Wang, Ruchong Chen, Fengyu Hu, et al.
EClinicalMedicine (2021) Vol. 40, pp. 101129-101129
Open Access | Times Cited: 216
Impact of the Delta variant on vaccine efficacy and response strategies
Lianlian Bian, Qiushuang Gao, Fan Gao, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1201-1209
Open Access | Times Cited: 215
Lianlian Bian, Qiushuang Gao, Fan Gao, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1201-1209
Open Access | Times Cited: 215
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events
Junxian Ou, Wendong Lan, Xiaowei Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 187
Junxian Ou, Wendong Lan, Xiaowei Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 187
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants
Veronika Tchesnokova, Hemantha D. Kulasekara, Lydia Larson, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 11
Open Access | Times Cited: 179
Veronika Tchesnokova, Hemantha D. Kulasekara, Lydia Larson, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 11
Open Access | Times Cited: 179